83 FR 42655 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 164 (August 23, 2018)

Page Range		42655-42656
FR Document		2018-18188

Federal Register, Volume 83 Issue 164 (Thursday, August 23, 2018)

[Federal Register Volume 83, Number 164 (Thursday, August 23, 2018)]
[Notices]
[Pages 42655-42656]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18188]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which

[[Page 42656]]

would constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE19-001, Injury Control 
Research Centers.
    Dates: October 30, 2018 and November 2, 2018
    Time: 8:30 a.m.-5:00 p.m., EDT
    Place: The Georgian Terrace, 659 Peachtree St. NE, Atlanta, GA, 
30308
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Mikel L. Walters, M.A., Ph.D., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop F-63, Atlanta, Georgia 30341, Telephone: (404) 639-0913; 
Email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-18188 Filed 8-22-18; 8:45 am]
 BILLING CODE 4163-18-P

42656 Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices

would constitute a clearly unwarranted INFORMATION CONTACT. The deadline for meeting. Public comments made in
invasion of personal privacy. receipt is October 15, 2018. attendance must be no longer than 3
Name of Committee: Disease, ADDRESSES: CDC, 1600 Clifton Road NE, minutes and the person giving
Disability, and Injury Prevention and Tom Harkin Global Communications comments must attend the public
Control Special Emphasis Panel (SEP)— Center, Kent ‘Oz’ Nelson Auditorium, comment session at the start time listed
RFA–CE19–001, Injury Control Research Atlanta, GA 30329–4027. on the agenda. Time for public
Centers. The meeting will be webcast live via comments may start before the time
Dates: October 30, 2018 and the World Wide Web; for instructions indicated on the agenda. The Director,
November 2, 2018 and more information on ACIP please Management Analysis and Services
Time: 8:30 a.m.–5:00 p.m., EDT visit the ACIP website: http:// Office, has been delegated the authority
Place: The Georgian Terrace, 659 www.cdc.gov/vaccines/acip/index.html. to sign Federal Register notices
Peachtree St. NE, Atlanta, GA, 30308 FOR FURTHER INFORMATION CONTACT: pertaining to announcements of
Agenda: To review and evaluate grant Stephanie Thomas, ACIP Committee meetings and other committee
applications. Management Specialist, CDC, NCIRD, management activities, for both the
For Further Information Contact: Centers for Disease Control and
telephone 404–639–8836, email ACIP@
Mikel L. Walters, M.A., Ph.D., Scientific Prevention and the Agency for Toxic
cdc.gov.
Review Official, NCIPC, CDC, 4770 Substances and Disease Registry.
Buford Highway NE, Mailstop F–63, SUPPLEMENTARY INFORMATION:
Atlanta, Georgia 30341, Telephone: Purpose: The committee is charged Sherri Berger,
(404) 639–0913; Email: mwalters@ with advising the Director, CDC, on the Chief Operating Officer, Centers for Disease
cdc.gov. use of immunizing agents. In addition, Control and Prevention.
The Director, Management Analysis under 42 U.S.C. 1396s, the committee is [FR Doc. 2018–18184 Filed 8–22–18; 8:45 am]
and Services Office, has been delegated mandated to establish and periodically BILLING CODE 4163–18–P
the authority to sign Federal Register review and, as appropriate, revise the
notices pertaining to announcements of list of vaccines for administration to
meetings and other committee vaccine-eligible children through the DEPARTMENT OF HEALTH AND
management activities, for both the Vaccines for Children (VFC) program, HUMAN SERVICES
Centers for Disease Control and along with schedules regarding dosing
Prevention and the Agency for Toxic interval, dosage, and contraindications Centers for Disease Control and
Substances and Disease Registry. to administration of vaccines. Further, Prevention
under provisions of the Affordable Care
Sherri Berger, Act, section 2713 of the Public Health [60Day–18–18ATK; Docket No.CDC–2018–
Chief Operating Officer, Centers for Disease Service Act, immunization 0075]
Control and Prevention. recommendations of the ACIP that have
[FR Doc. 2018–18188 Filed 8–22–18; 8:45 am] Proposed Data Collection Submitted
been approved by the Director of the
for Public Comment and
BILLING CODE 4163–18–P Centers for Disease Control and
Recommendations
Prevention and appear on CDC
immunization schedules must be AGENCY: Centers for Disease Control and
DEPARTMENT OF HEALTH AND covered by applicable health plans. Prevention (CDC), Department of Health
HUMAN SERVICES Matters to Be Considered: The agenda and Human Services (HHS).
will include discussions on child/ ACTION: Notice with comment period.
Centers for Disease Control and adolescent immunization schedule,
Prevention adult immunization schedule, human SUMMARY: The Centers for Disease
Meeting of the Advisory Committee on papillomavirus vaccines, pneumococcal Control and Prevention (CDC), as part of
Immunization Practices vaccines, Japanese encephalitis its continuing effort to reduce public
vaccines, zoster vaccine, Influenza burden and maximize the utility of
AGENCY: Centers for Disease Control and vaccines, general recommendations, government information, invites the
Prevention (CDC), Department of Health anthrax vaccine, hepatitis A vaccine, general public and other Federal
and Human Services (HHS). Pertussis vaccine, and meningococcal agencies the opportunity to comment on
ACTION: Notice of meeting. vaccines. A recommendation vote is a proposed and/or continuing
scheduled for child/adolescent information collection, as required by
SUMMARY: In accordance with the immunization schedule and adult the Paperwork Reduction Act of 1995.
Federal Advisory Committee Act, the immunization schedule. Agenda items This notice invites comment on a
CDC announces the following meeting are subject to change as priorities proposed information collection project
of the Advisory Committee on dictate. For more information on the titled Understanding multi-sectoral
Immunization Practices (ACIP). This meeting agenda visit https:// collaboration for strengthening public
meeting is open to the public, limited www.cdc.gov/vaccines/acip/meetings/ health capacities in Ethiopia. The goal
only by room seating. The meeting room meetings-info.html. of this study is to explore multi-sectoral
accommodates 400. Time will be Public Comment: Written comments collaboration in Ethiopia, in the context
available for public comment. must include full name, address, of strengthening public health capacities
DATES: The meeting will be held on organizational affiliation, email address under the Global Health Security
October 24, 2018, 8:30 a.m. to 5:15 p.m., of the speaker, topic being addressed Agenda.
daltland on DSKBBV9HB2PROD with NOTICES

EDT, and October 25, 2018, 8:30 a.m. to and specific comments. Written
4:00 p.m. EDT. comments must not exceed one single- DATES:CDC must receive written
The public is welcome to submit spaced typed page with 1-inch margins comments on or before October 22,
written comments in advance of the containing all items above. Only those 2018.
meeting. Comments should be written comments received 10 business ADDRESSES: You may submit comments,
submitted in writing by email to the days in advance of the meeting will be identified by Docket No. CDC–2018–
contact person listed in FOR FURTHER included in the official record of the 0075 by any of the following methods:

VerDate Sep<11>2014 19:43 Aug 22, 2018 Jkt 244001 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\23AUN1.SGM 23AUN1

Document Created: 2018-08-23 00:34:03
Document Modified: 2018-08-23 00:34:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 30, 2018 and November 2, 2018
Contact		Mikel L. Walters, M.A., Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341, Telephone: (404) 639-0913; Email: [email protected]
FR Citation		83 FR 42655

83 FR 42655 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 164 (August 23, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention